Trevena Inc. | Mutual Funds
Mutual Funds that own Trevena Inc.
Vanguard Total Stock Market Index Fund
1,192,783
1.57%
0
0%
07/31/2018
Fidelity Select Biotechnology Portfolio
1,105,549
1.45%
0
0.02%
07/31/2018
Fidelity Blue Chip Growth Fund
957,837
1.26%
0
0.01%
07/31/2018
PZU FIO Parasolowy - Energia Medycyna Ekologia
900,000
1.18%
656,710
1.89%
06/30/2017
Fidelity Large Cap Stock Fund
751,196
0.99%
0
0.04%
07/31/2018
Vanguard Extended Market Index Fund
688,797
0.91%
0
0%
07/31/2018
Hartford Healthcare Fund
680,062
0.89%
-12,467
0.08%
07/31/2018
Fidelity Advisor Capital Development Fund
581,500
0.76%
0
0.03%
07/31/2018
DFA US Small Cap Portfolio
560,685
0.74%
0
0.01%
04/30/2018
Fidelity OTC Portfolio
512,521
0.67%
0
0%
07/31/2018
| Address |
955 Chesterbrook Boulevard
Chesterbrook Pennsylvania 19087
United States
|
|
Employees
|
- |
| Website |
http://www.trevenainc.com |
| Updated |
07/08/2019 |
| Trevena, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of healthcare services and development of therapies. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. |
